Target intelligence / Profile preview

microRNA 1468 (MIR1468)

Target
MIR1468
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA 1468 (MIR1468) is a human-specific microRNA found in the heart, brain, and other tissues. As a microRNA, it functions primarily by binding to complementary sequences in the 3' untranslated regions of messenger RNAs, leading to their degradation or inhibition of translation[1][3]. Variant forms (miR-1468-3p and miR-1468-5p) have distinct tissue roles:\n\n- miR-1468-3p promotes aging-related cardiac fibrosis and cellular senescence, acting via enhancement of TGF-β1/p38 MAPK signaling and inhibition of dual-specificity phosphatases (DUSP1, DUSP6, DUSP8)[3].\n- miR-1468-5p functions as a tumor suppressor in glioma, inhibiting cell growth and cell cycle progression by targeting the ribonucleotide reductase large subunit M1 (RRM1)[2].\n\nExpression of MIR1468 can serve as a biomarker for disease severity or tissue aging, and antagonists ("antimiRs") of this microRNA are being studied as therapeutic agents to target cardiac fibrosis and tumor cell growth[2][3]. As a microRNA, MIR1468 is part of a molecular family involved in fine-tuning cellular phenotypes, notably in post-transcriptional regulation networks[1].

Other names
hsa-mir-1468MIRN1468mir-1468miR-1468-3pmiR-1468-5p
02

Mechanism of action

Synthetic antimiRs can antagonize miR-1468-3p, blocking its pro-fibrotic and senescence-inducing activities in tissue. miR-1468-5p acts as a tumor suppressor via direct inhibition of target mRNAs, such as RRM1 in glioma cells.

03

Biological functions

Gene silencing/post-transcriptional regulationCell cycle regulationCell proliferationCellular senescenceExtracellular matrix synthesis (fibrosis)
04

Disease associations

Cancer (glioma)Cardiovascular disease (cardiac fibrosis, aging-related fibrosis)Potentially other age-related diseases
05

Safety considerations

Modulating microRNAs may affect numerous pathways due to their broad gene regulation, raising risks of off-target effectsSpecific safety/therapeutic challenges have not yet been systematically defined for MIR1468-based therapies
06

Interacting drugs

antimiR-1468-3p
07

Biomarkers

Expression levels of miR-1468-3p as a biomarker of aging-related cardiac fibrosisDownregulation of miR-1468-5p as a marker of glioma malignancy and prognosis

Beyond the preview

Go deeper on microRNA 1468 (MIR1468).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 1468 (MIR1468).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call